Mandelberg 1999.

Methods	Randomised double‐blind placebo controlled cross‐over trial conducted in Israel Fisher's exact, post‐hoc t‐test
Participants	17 CRF patients referred to Nehprology Unit between October 1, 1997 and March 31, 1998 for haemodialysis
Interventions	Group 1: 1200 ug salbutamol through MDS‐I followed by placebo versus Group 2: placebo, then 1200 μg salbutamol through MDS‐I
Outcomes	Serum potassium Insulin levels
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Low risk	A ‐ Adequate